Search - tctmd.com

Displaying 201 - 220 of 225

Sort: Relevancy | Date

News Daily News

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

September 05, 2012

News Daily News

Tras Implantar la Válvula Sapien No suele hacerse Necesario un Marcapasos Permanente

L.A. McKeown

July 18, 2012

News Daily News

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

L.A. McKeown

July 18, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Presentation GI2 2012

Thrombo Aspiration and Covered Stents

Presenter: Ron Waksman

April 13, 2012

Presentation GI2 2012

How to Reduce Contrast Induced Nephropathy in Interventional Procedures

Presenter: Ron Waksman

April 13, 2012

Presentation GI2 2012

What Technology Modifications Required for Bioabsorbable Scaffolds to Broaden Indications for USE

Presenter: Ron Waksman

April 12, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

Presentation ISET 2012

Clinical Experience with the TAVI: Update on the Partners Trial

Presenter: Ron Waksman

January 16, 2012

Presentation ISET 2012

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Presenter: Ron Waksman

January 15, 2012

Presentation TCT 2012

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Presenter: Israel M. Barbash, Rebecca Torgusson, Itsik Ben-Dor, Gabriel Maluenda, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Predictors and Clinical Outcome of Patients with Acute Kidney Injury Following Trans-Cutaneous Aortic Valve Replacement.

Presenter: Israel M. Barbash, Itsik Ben-Dor, Gabriel Maluenda, Paul J. Corso, Steven A. Goldstein, Zuyue Wang, Rebecca Torguson, Lowell F. Satler, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Does Left Atrial Diameter in Patients with Severe Aortic Stenosis Have a Clinical Impact on Outcome?

Presenter: Camille Hauville, Itsik Ben-Dor, Ana Laynez-Carnicero, Gabriel Sardi, Gabriel Maluenda, Israel M. Barbash, Manuel A. Gonzalez, Michael A. Gaglia, Rebecca Torguson, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph M. Lindsay, Augusto D. Pichard, Ron Waksman

January 03, 2012

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Daily News

DISCOVER-FLOW Published: Noninvasive FFR Shows High Diagnostic Accuracy

Leah Lawrence

October 24, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

Advertisement

Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis

Tras Implantar la Válvula Sapien No suele hacerse Necesario un Marcapasos Permanente

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Thrombo Aspiration and Covered Stents

How to Reduce Contrast Induced Nephropathy in Interventional Procedures

What Technology Modifications Required for Bioabsorbable Scaffolds to Broaden Indications for USE

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Clinical Experience with the TAVI: Update on the Partners Trial

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Predictors and Clinical Outcome of Patients with Acute Kidney Injury Following Trans-Cutaneous Aortic Valve Replacement.

Does Left Atrial Diameter in Patients with Severe Aortic Stenosis Have a Clinical Impact on Outcome?

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

DISCOVER-FLOW Published: Noninvasive FFR Shows High Diagnostic Accuracy

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content